Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Locally or Centrally Administered Ginkgo Extract Reduced Pain and Inflammation in Rat Model

By LabMedica International staff writers
Posted on 11 May 2011
A standardized extract from Ginkgo biloba administered either locally or centrally reduced chemically induced inflammation or pain in a rat model.

Investigators at Glasgow Caledonian University (United Kingdom) sought to determine the site of action of the standardized ginkgo extract EGb 761 by evaluating the antihyperalgesic and anti-inflammatory properties of EGb 761 after local and central drug administration in the rat carrageenan model of inflammation. More...


The investigators injected adult male Wistar rats with carrageenan (3%) or saline into the left hindpaw followed three hours later by a local injection of EGb 761 or vehicle or injection of EGb 761 or vehicle into the lumbar spinal cord region. Other animals received injections of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac as a positive control.

Results published in the May 2011 issue of the journal Anesthesia & Analgesia revealed that EGb 761--injected either into the spinal canal or directly into the injured area--effectively reduced inflammation and some types of pain. In reducing thermal hyperalgesia, it was just as effective as diclofenac. The EGb 761 effectively reduced swelling in the paw swelling, even when injected into the spinal canal. EGb 761, in contrast to diclofenac had no effect on abnormal responses to mechanical stimuli, such as a pinprick (mechanical hyperalgesia).

Senior author Dr. Sharron Dolan, senior lecturer in biological and biomedical sciences at Glasgow Caledonian University, said, "These studies indicate that EGb 761 may offer therapeutic benefit for the treatment of postinjury-associated thermal hyperalgesia and acute inflammation."

Related Links:
Glasgow Caledonian University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.